EP3169328
Kínólín-afleiður til meðhöndlunar á bólgusjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.7.2015EP published:
9.3.2022EP application number:
15738916.4
EP translation filed:
17.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
16.7.2035Expiry date:
16.7.2026Next due date:
31.7.2026
Title in English:
QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASESLanguage of the patent:
English
Timeline
Today
17.7.2015EP application
9.3.2022EP Publication
17.5.2022Translation submitted
15.6.2022Registration published
16.7.2026Expires
Owner
Name:
ABIVAXAddress:
5 rue de la Baume, 75008 Paris, FR
Name:
Centre National de la Recherche ScientifiqueAddress:
3, rue Michel Ange, 75794 Paris Cedex 16, FR
Name:
Institut CurieAddress:
26, rue d'Ulm, 75248 Paris Cedex 05, FR
Name:
Université de MontpellierAddress:
163 Rue Auguste Broussonnet, 34090 Montpellier, FR
Inventor
Name:
TAZI, JamalAddress:
F-34380 Clapiers, FR
Name:
NAJMAN, RomainAddress:
F-94240 L'Hay-les-Roses, FR
Name:
MAHUTEAU, FlorenceAddress:
F-78470 Saint Remy Les Chevreuses, FR
Name:
SCHERRER, DidierAddress:
F-34170 Castelnau Le Lez, FR
Name:
HAHNE, MichaelAddress:
F-34090 Montpellier, FR
Name:
CHEBLI, KarimAddress:
F-34110 Frontignan, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14306164Date:
17.7.2014Country:
EP
Classification
Categories:
A61K 31/47, A61K 31/4709, A61K 31/497, A61K 31/5377, G01N 33/50, C07D 401/12, C07D 215/38, C12Q 1/6883, A61P 1/04, A61P 1/00, A61P 9/10, A61P 11/00, A61P 11/06, A61P 17/00, A61P 17/06, A61P 19/02, A61P 21/00, A61P 25/00, A61P 25/16, A61P 25/28, A61P 29/00, A61P 35/00, A61P 37/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 21.6.2022
Expires: 16.7.2023
Payer: Patice ehf.
Number: 9
Paid: 22.6.2023
Expires: 16.7.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.7.2024
Expires: 16.7.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 10.7.2025
Expires: 16.7.2026
Payer: G.H. Sigurgeirsson ehf.